Kidney transplantation is the preferred treatment for patients suffering from end-stage renal disease (ESRD), significantly improving both survival rates and quality of life compared to indefinite dialysis. In the last twenty years, China has rapidly established itself as a leading global center for organ transplantation. The country now boasts a sophisticated system that consistently delivers high-volume, highly successful kidney transplant procedures, with clinical outcomes comparable to those seen in Western healthcare systems.
China has established a rigorous and reformed regulatory system for organ transplantation, centered on the National Organ Donation and Transplant System and the China Organ Transplantation Response System (COTRS). This central management ensures transparency and ethical allocation from deceased donors. The "Regulation on Human Organ Transplantation" (2007) legally mandates that all transplants serve legitimate medical purposes while strictly outlawing commercialism and organ trafficking. This ethical, government-led structure aligns with World Health Organization (WHO) principles, a fact recognized by the Transplantation Society (TTS) as evidence of China's progress. Fuelled by this robust framework and increasing surgical capacity, China now performs the world's second-highest volume of organ transplants annually, showing significant, sustained growth in both liver and kidney procedures, as verified by COTRS data.
Comprehensive medical assessment and compatibility testing
Medical optimization and surgical planning
Advanced surgical techniques by expert transplant teams
Comprehensive follow-up and immunosuppressive management
China now performs the world's second-highest volume of organ transplants annually, showing significant, sustained growth in both liver and kidney procedures, as verified by COTRS data. The program, especially for kidney transplants, shows significant growth in volume, demonstrating the massive scale of the national effort (verified by COTRS data) in the below chart;
Long-term patient and graft survival rates, the definitive metrics for evaluating any transplant program, underscore the success of China's reformed system. Specifically, data collected by the China Scientific Registry of Kidney Transplantation (CSRKT), an entity that actively shares and compares its findings with international registries, validates that the clinical outcomes achieved in China's most advanced centers are on par with, or internationally competitive against, global standards.
| Country | Living Donor | Deceased Donor | Follow-up Care | Total Package |
|---|---|---|---|---|
| China | $45,000 | $40,000 | $5,000 | $50,000 |
| India | $18,000 | $15,000 | $3,000 | $21,000 |
| Thailand | $65,000 | $60,000 | $8,000 | $73,000 |
| USA | $400,000 | $350,000 | $50,000 | $450,000 |
Beyond high volume, Chinese transplant centers are global leaders in surgical innovation and patient management.
Chief of Kidney Transplantation
Leading kidney transplant surgeon with over 20 years of experience and more than 2,000 successful transplant procedures. Pioneer in minimally invasive transplant techniques and immunosuppressive protocols.
Uncover world-class hospitals equipped with cutting-edge technology and renowned experts, guaranteeing exceptional success for a healthier future.
Advanced transplant center with state-of-the-art surgical suites
Comprehensive transplant program with research facilities
Contact our medical coordinators for a personalized consultation and treatment plan.